Metanx is a medical food made by Pamlab that contains L-methylfolate (vitamin B9) methylcobalamin (vitamin B12) and pyridoxal 5′-phosphate (vitamin B6). It is a vitamin B supplement.It is indicated for […]
List of articles in "Drug" category - Page 269
Tesaglitazar
Tesaglitazar (AZ 242) is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ proposed for type 2 diabetes.The drug had completed several phase III clinical trials however in […]
Niacin/lovastatin
Niacin/lovastatin (trade names Advicor Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of the vitamin niacin and the statin drug lovastatin. The combination […]
Muraglitazar
Muraglitazar (proposed tradename Pargluva) is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ.The drug had completed phase III clinical trials however in May 2006 Bristol-Myers Squibb announced […]
Vernakalant
Vernakalant (INN; codenamed RSD1235 proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma […]
Tedisamil
Tedisamil (37-dicyclopropylmethyl-99-tetramethylene-37-diazabicyclo-331-nonane) is an experimental class III antiarrhythmic agent currently being investigated for the treatment of atrial fibrillation. Tedisamil blocks multiple types of potassium channels in the heart resulting in […]
Fosaprepitant
Fosaprepitant (Emend for Injection (US) Ivemend (EU)) is an antiemetic drug administered intravenously. It is a prodrug of aprepitant.Fosaprepitant was developed by Merck & Co. and was approved by the […]
Rilonacept
Rilonacept also known as IL-1 Trap (marketed by Regeneron Pharmaceuticals under the trade name Arcalyst) is an interleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains […]
Ro48-6791
Ro48-6791 is a drug a benzodiazepine derivative developed by Hoffman-LaRoche in the 1990s.Ro48-6791 was developed as an alternative to the short-acting imidazobenzodiazepine midazolam for use in induction of anaesthesia and […]
Rivoglitazone
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes.It is being developed by Daiichi Sankyo Co.